RT Journal Article
SR Electronic
T1 GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 1017
OP 1023
VO 68
IS 12
A1 Chew, Derek P.
A1 Moliterno, David J.
YR 2001
UL http://www.ccjm.org/content/68/12/1017.abstract
AB Recent clinical trials have refined our understanding of how the glycoprotein (GP) IIb/IIIa inhibitors should best be used. These trials examined whether there are clinical differences between agents, whether empiric use of GP IIb/IIIa inhibitors in acute coronary syndromes is justified, and whether these drugs might allow for early invasive management in acute coronary syndromes.